Eli Lilly stock pulls back from record high after disclosing sales by largest shareholder


Shares of Eli Lilly & Co. LLY, -3.10% fell 4.0% in afternoon trading Tuesday, to pullback from the previous session’s record close, after the drug maker disclosed that its largest shareholder sold nearly $64 million worth of its shares. In a Form 4 filing with the Securities and Exchange Commission, the company said Lilly Endowment Inc., a private philanthropic foundation, sold 200,000 Eli Lilly shares in the open market on May 27. The sales were executed in a series of trades ranging from $314.44 to $323.421. Based on a MarketWatch calculation of the data provided, the weighted average price of the sales was $318.983, which compares with the May 27 trading range of $311.26 to $324.08, and record closing price of $323.48. After the sales, Lilly Endowment still owns 104.83 million Lilly shares, or about 11.0% of the shares outstanding, which at current stock prices would be valued at about $32.56 billion. Lilly’s stock has rallied 12.4% year to date, while the SPDR Health Care Select Sector ETF XLV, -1.34% has lost 6.4% and the S&P 500 SPX, -0.63% has dropped 13.4%.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleThe Fed: Exclusive: Fed’s Bostic says idea of September pause is not tied to any looming market rescue
Next articleChicago regional PMI gauge outruns expectations in May


Please enter your comment!
Please enter your name here